FDA recommends new rules for cannabidiol products
The FDA has suggested new regulations for the use of cannabidiol products, as the existing rules on food and supplements were insufficient for.
Drugs
Health
Pharma
Drugs
Medical
Pharma
Roche unveils test to trace fast-spreading Omicron variant
Roche, a Swiss multinational healthcare company, has unveiled a new test for targeting the fast-spreading XBB.1.5 Omicron sub-variant.
Drugs
Medical
Pharma
India’s Bharat Biotech rolls out Covid-19 nasal drop vaccine
Bharat Biotech, an Indian maker of vaccines for infectious diseases, has rolled out the world's first nasal Covid-19 drops as a booster dose,.
Drugs
Medical
Pharma
Antibiotic shortage forces EU to take measures
A group of European patient and consumer organisations has written a letter to the European Medicines Agency (EMA) expressing concern over the shortage.
Drugs
Medical
Pharma
US health regulator says heart devices recall “most serious”
A recall of Swedish makers' of heart devices has been classified by the FDA as "most serious" since they could lead to severe.
Drugs
Pharma
Eli Lilly plans $450 million extra to expand Research Triangle
Eli Lilly will invest an additional $450 million to expand its manufacturing capacity at Research Triangle Park facility in North Carolina.
Drugs
Pharma
WHO urges “immediate” action on falsified medicines
The WHO called on stakeholders in various nations to take “immediate and coordinated action” to shield children from using contaminated cough syrups following.
Drugs
Pharma
Merck says it has identified the cause of contamination of its diabetes medicines
Merck says its diabetes drugs got contaminated during storage and manufacturings and it will improve the same to prevent it in future
Health
Pharma
High global food prices leave less food on plates of Latin America, Caribbean
More than 131 million people in the Latin American and Caribbean population are not able to afford a healthy diet, due to high.
Drugs
Pharma
Johnson & Johnson pulls out of HIV phase III trial
Johnson & Johnson stopped the phase III trial of its global HIV vaccine trial after it found that the regimen was ineffective in.